MISSION STATEMENT The Mission of HOA is to provide the highest level of quality care in a healing environment for the mind, body and spirit of patients dealing with cancer and blood disorders. Our goal is to offer the highest level, state of the art technology and treatments, while meeting the emotional needs of our […]

MISSION STATEMENT/PHILOSOPHY: Joliet Oncology-Hematology Associates, Ltd. strives to continually improve the quality of life of our cancer patients; to provide patients with the highest quality of cancer care in an open supportive and compassionate environment;

Mission Statement: Our promise is a quality-driven service, and our aim is to ensure affordable access to our patients.

Congratulations to NCODA member Gina Wertz, PharmD as her practice, Nebraska Hematology Oncology (NHO), launched their first medically integrated dispensary (MID) on Tuesday, April 17th, 2018.

Oral anticancer medications are frequently used to treat patients with cancer. Dr. Daniel Geynisman and his team found significant time and energy burdens for clinic staff and patients in obtaining these drugs. Read more here.

American Journal of Managed Care – A generation ago, doctors made decisions, and everyone else adapted. The rise of patient-centered care has changed the game, making medicine a team effort, in which the physician collaborates with nurses, social workers, nutritionists, and other specialists. Most of all, physicians seek input from patients themselves. This is especially true […]

The American Journal of Managed Care > April 2018  – Oral anticancer medications are frequently used to treat patients with cancer. We found significant time and energy burdens for clinic staff and patients in obtaining these drugs. …. As payers and healthcare providers examine methods for quality improvement, they should consider improved processes to facilitate […]

Chris Kepinski speaking at AJMC’s Institute for Value-Based Medicine NCODA member Chris Kepinski, clinical oncology pharmacy manager for Southern Oncology Specialists in North Carolina, recently spoke on a national panel regarding advancing quality in oncology care as part of the Institute for Value-Based Medicine, a new initiative of The American Journal of Managed Care. Read entire article in […]

This article in the AJMC discusses the positive quality interventions space within oncology dispensing. NCODA member Laura Joszt, 2018 NCODA Spring Forum attendee, explains NCODA’s efforts to improve patient care with best practices. Positive quality interventions are part of a nationwide effort to standardize and improve oncology dispensing practices. They are best practices that are meant […]

MISSION STATEMENT A Private Hematology and Oncology Specialty Practice offering exceptional care to each of our patients’ individual hematology and oncology specific needs.

The addition of abemaciclib (Verzenio) to initial treatment with a nonsteroidal aromatase inhibitor appeared effective for women with hormone receptor-positive, HER-2-negative advanced breast cancer, according to results of the double-blind, phase 3 MONARCH 3 study presented at American Association for Cancer Research Annual Meeting. Read More Here 

Basilea Pharmaceutica Ltd. (SIX: BSLN) announced on 4/17/18 that it has entered into a license agreement with ArQule, Inc. (NASDAQ: ARQL) for its oral oncology drug candidate ARQ 087 (derazantinib), which targets the fibroblast growth factor receptor (FGFR) family of kinases. Read More Here